Inclusion Criteria:

- Age 2 to 7 years of age

- Diagnosis of Autistic Disorder as diagnosed by the DSM-IV-TR developmental delays,
and ADOS

- A sufficient quantity of autologous cord blood stored at Cord Blood Registry that was
stored and processed using the Thermogenesis AutoXpress Platform

- Stable on any current medications for at least 2 months prior to infusion of cord
blood

- Medical records indicating that patient does not have genetic conditions such as
cerebral palsy, cystic fibrosis, muscular dystrophy, crohns disease, rheumatoid
disease, fragile X, Retts Syndrome, Angelman Syndrome, tuberous sclerosis, epilepsy,
or known genetic defects that overlap autism spectrum.

- Results of an EEG within 12-months of baseline

- English speaking

Exclusion Criteria:

- CNS infection

- Extreme prematurity (< 34 weeks gestation)

- Severe Cognitive Disability IQ below 45 with autism

- Clinical seizure activity within 6 months of baseline

- Lennox Gastaut syndrome or infantile spasms

- Dravet syndrome

- HIV, renal or hepatic impairment

- Prior hematological or malignant disease

- Fever of 101 F within 2 weeks prior to infusion

- Serious CNS infection or trauma

- Unwilling to commit to follow-up

- Mental illness including schizophrenia

- Pervasive Developmental Disorder—Not Otherwise Specified

- Asperger's Disorder

- Cord blood unit is less than 85% viable, has a TNC of less than 10 million/kg, CD34+
count of less than 0.3% or sterility testing results are positive

- Garlic allergy

- Previous adverse reaction to Dimethyl Sulfoxide (DMSO)

- Maternal medical records indicate communicable diseases including HIV, Hepatitis B or
C, syphilis, cytomegalovirus (CMV)

- Currently taking anti-inflammatory medications

- History of asthma who may potentially require treatment with steroids

- Inflammatory Disease

- Renal/hepatic disease: serum Creatinine > 1.5 mg/dl and total Bilirubin > 1.5 mg/dl

- Allergic to diphenhydramine (Benadryl)